
Inflammatix has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s lead …

Acurx Pharmaceuticals has announced that it has discontinued its phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for …

Recce Pharmaceuticals has announced that it has completed its data analysis for its phase 1/2 clinical trial of Recce 327 …

A man in Hong Kong has been reinfected with the coronavirus, stoking fears that immunity to the virus may be …

The Florida Department of Health has issued a warning over a rare case of ‘brain-eating’ amoeba after one person has …

Researchers working with the non-profit organisation the International AIDS Vaccine Initiative (IAVI) have announced the launch of a Phase I …
The world is heading for a situation where common infections which have long been thought to be no threat to …
Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …
How did you find your way into your role? I wanted to be a chemist from my very first experience …